InterPATH-001 Trial in Progress: Adjuvant V940 (Mrna-4157) with Pembrolizumab Versus Placebo in Patients with High-Risk Stage II-IV Melanoma
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined